Horan Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.04M Buy
18,305
+228
+1% +$35.7K 1.02% 37
2024
Q4
$2.61M Sell
18,077
-5
-0% -$775 0.88% 38
2024
Q3
$2.93M Sell
18,082
-177
-1% -$28.2K 0.97% 38
2024
Q2
$2.67M Sell
18,259
-40
-0.2% -$5.95K 0.94% 40
2024
Q1
$2.89M Sell
18,299
-63
-0.3% -$10K 1.03% 39
2023
Q4
$2.88M Sell
18,362
-178
-1% -$27.3K 1.06% 37
2023
Q3
$2.89M Sell
18,540
-494
-3% -$81.5K 1.16% 31
2023
Q2
$3.15M Buy
19,034
+99
+0.5% +$16K 1.23% 29
2023
Q1
$2.93M Buy
18,935
+357
+2% +$57.6K 1.21% 31
2022
Q4
$3.28M Sell
18,578
-297
-2% -$51.3K 1.44% 27
2022
Q3
$3.08M Buy
18,875
+373
+2% +$63.1K 1.49% 25
2022
Q2
$3.28M Sell
18,502
-9
-0% -$1.6K 1.53% 23
2022
Q1
$3.28M Buy
18,511
+205
+1% +$34.9K 1.32% 31
2021
Q4
$3.13M Buy
18,306
+338
+2% +$55.3K 1.24% 32
2021
Q3
$2.9M Sell
17,968
-76
-0.4% -$13K 1.28% 31
2021
Q2
$2.97M Buy
18,044
+1,865
+12% +$309K 1.34% 31
2021
Q1
$2.66M Buy
16,179
+285
+2% +$46.1K 1.28% 31
2020
Q4
$2.5M Buy
15,894
+537
+3% +$79.2K 1.29% 30
2020
Q3
$2.29M Buy
15,357
+257
+2% +$38K 1.29% 29
2020
Q2
$2.12M Sell
15,100
-200
-1% -$29.1K 1.43% 28
2020
Q1
$2.01M Buy
15,300
+390
+3% +$55.3K 1.6% 25
2019
Q4
$2.17M Sell
14,910
-351
-2% -$47.6K 1.29% 31
2019
Q3
$1.97M Sell
15,261
-173
-1% -$22.8K 1.21% 40
2019
Q2
$2.15M Sell
15,434
-465
-3% -$64.4K 1.45% 33
2019
Q1
$2.22M Sell
15,899
-1,407
-8% -$188K 1.41% 32
2018
Q4
$2.23M Buy
17,306
+185
+1% +$25.8K 1.5% 32
2018
Q3
$2.37M Sell
17,121
-382
-2% -$50.8K 1.52% 34
2018
Q2
$2.12M Buy
17,503
+210
+1% +$26.2K 1.36% 35
2018
Q1
$2.22M Buy
17,293
+25
+0.1% +$3.38K 1.45% 34
2017
Q4
$2.41M Sell
17,268
-301
-2% -$41.9K 1.57% 30
2017
Q3
$2.28M Buy
17,569
+229
+1% +$30.4K 1.41% 34
2017
Q2
$2.29M Buy
17,340
+821
+5% +$105K 1.56% 30
2017
Q1
$2.06M Buy
16,519
+398
+2% +$47.5K 1.47% 36
2016
Q4
$1.86M Buy
16,121
+93
+0.6% +$10.7K 1.39% 38
2016
Q3
$1.89M Buy
16,028
+436
+3% +$52.9K 1.5% 35
2016
Q2
$1.89M Sell
15,592
-512
-3% -$58.2K 1.54% 34
2016
Q1
$1.74M Buy
16,104
+675
+4% +$69.9K 1.35% 36
2015
Q4
$1.58M Sell
15,429
-1,464
-9% -$147K 1.32% 35
2015
Q3
$1.58M Buy
+16,893
New +$1.63M 1.33% 40
2015
Q2
Sell
-22,530
Closed -$2.26M 25
2015
Q1
$2.27M Sell
22,530
-122
-0.5% -$12.4K 1.89% 26
2014
Q4
$2.37M Buy
22,652
+1,532
+7% +$161K 1.96% 16
2014
Q3
$2.25M Buy
21,120
+4,142
+24% +$430K 1.99% 15
2014
Q2
$1.78M Buy
16,978
+1,240
+8% +$125K 1.62% 26
2014
Q1
$1.55M Buy
15,738
+2,230
+17% +$207K 1.49% 30
2013
Q4
$1.24M Buy
13,508
+445
+3% +$41K 1.26% 37
2013
Q3
$1.13M Buy
13,063
+495
+4% +$44.4K 1.35% 35
2013
Q2
$1.08M Buy
+12,568
New +$1.07M 1.64% 27

Other funds holding JNJ

Horan Capital Advisors's JNJ Position: Q1 2025 in Review

Horan Capital Advisors increased its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2025, buying an estimated $35.7K and bringing the position to 18,305 shares worth $3.04M. The position accounts for 1.02% of the portfolio, ranked #37.

Horan Capital Advisors first reported a position in JNJ in Q2 2013 and has held it in 47 quarters since. The position peaked at $3.28M in Q2 2022. 4,150 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Horan Capital Advisors held 18,305 shares of Johnson & Johnson worth $3.04M as of Q1 2025.
  • Horan Capital Advisors bought 228 Johnson & Johnson shares in Q1 2025, an estimated $35.7K.
  • Johnson & Johnson made up 1.02% of Horan Capital Advisors's portfolio in Q1 2025, its #37 holding.
  • Horan Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 47 quarters since.
  • Horan Capital Advisors's Johnson & Johnson position peaked at $3.28M in Q2 2022.
  • 4,150 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Horan Capital Advisors's 13F filing for Q1 2025, filed 7 May 2025.